Review Articles |
Antisense oligonucleotides in rare neurogenetic disorders
|
Hui Jin Shin, Ara Ko, Ji Young Oh, and Hoon-Chul Kang |
Journal of Genetic Medicine 2024;21:41-50 |
|
Recent advances in Neurofibromatosis type 1 research: Towards tailored therapeutics and treatment strategies
|
Su Jung Park |
Journal of Genetic Medicine 2024;21:51-60 |
|
|
Original Articles |
Chromosomal microarray analysis in pregnancies with prenatal ultrasound abnormalities according to the involved organ systems
|
Na Kyung Yu, Bohye Gil, Kirim Hong, Soo Hyun Kim, Hee-Jin Park, Moon Young Kim, Dong Hyun Cha, and You Jung Han |
Journal of Genetic Medicine 2024;21:61-65 |
|
Molecular and clinical delineation of patients with fatty acid oxidation disorder: A single center’s experience
|
Minji Kim, Sukdong Yoo, and Chong Kun Cheon |
Journal of Genetic Medicine 2024;21:66-73 |
|
|
Case Report |
Salih myopathy and Feingold syndrome type 1 caused by the TTN and MYCN mutation in an infant with congenital hypotonia
|
Eunseong Seo, Dohyung Kim, Soojin Hwang, June-Young Koh, Young Seok Ju, Gu-Hwan Kim, and Beom Hee Lee |
Journal of Genetic Medicine 2024;21:74-79 |
|